Roche's Tecentriq goes back to its roots with chemo combo win in bladder cancer
admin 5th August 2019 Uncategorised 0Back in 2016, Roche’s Tecentriq became the first in its class of immuno-oncology drugs to break into the bladder cancer arena. And it’s now in position to become the first into the previously untreated market, too.
More: Roche's Tecentriq goes back to its roots with chemo combo win in bladder cancer
Source: fierce